Critical dose of lead affecting δ-aminolevulinic acid levels

Journal of Occupational Health

Volumn 45, Issue 4, 2003, Pages 209-214

  Murata, Katsuyuki ^a,b   Sakai, Tadashi ^c   Morita, Yoko ^c   Iwata, Toyoto ^a   Dakeishi, Miwako ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b School of Medicine   (Japan)

^c NONE

Author keywords

Aminolevulinic acid; Aminolevulinic acid dehydratase; Adverse effect; Critical dose; Lead; Occupational exposure

Indexed keywords

AMINOLEVULINIC ACID; LEAD; PORPHOBILINOGEN SYNTHASE;

ADULT; ARTICLE; DRUG SURVEILLANCE PROGRAM; ENZYME ACTIVITY; HUMAN; JAPAN; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; URINE LEVEL;

ADOLESCENT; ADULT; AMINOLEVULINIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LEAD; MAXIMUM ALLOWABLE CONCENTRATION; MIDDLE AGED; OCCUPATIONAL EXPOSURE;

EID: 0041972193     PISSN: 13419145     EISSN: None     Source Type: Journal    
DOI: 10.1539/joh.45.209     Document Type: Article

References (25)

1. International Programme on Chemical Safety. Environmental Health Criteria 165: Inorganic Lead. Geneva: World Health Organization, 1995
2. T Sakai: Biomarkers of lead exposure. Ind Health 38, 127-142 (2000)
3. S Selander and K Cramer: Interrelationships between lead in blood, lead in urine and ALA in urine during lead work. Br J Ind Med 27, 28-39 (1970)
4. PA Meredith, MR Moore, BC Campbell, GG Thompson and A Goldberg: Delta-aminolevulinic acid metabolism in normal and lead-exposed humans. Toxicology 9, 1-9 (1978)
5. R Lauwerys, JP Buchet, HA Roels and DD Materne: Relationship between urinary δ-aminolevulinic acid excretion and the inhibition or red cell δ-aminolevulinate dehydratase by lead. Clin Toxicol 7, 383-388 (1974)
6. HA Roels and R Lauwerys: Evaluation of dose-effect and dose-response relationships for lead exposure in different Belgian population groups (foetus, child, adult men and women). Trace Elem Med 4, 80-87 (1987)
7. K Higashikawa, K Furuki, S Takada, S Okamoto, H Ukai, T Yuasa and M Ikeda: Blood lead level to induce significant increase in urinary δ-aminolevulinic acid level among lead-exposed workers: a statistical approach. Ind Health 38, 181-188 (2000)
8. National Research Council. Toxicological Effects of Methylmercury. Washington DC: National Academy Press, 2000
9. K Crump: Calculation of benchmark doses from continuous data. Risk Anal 15, 79-89 (1995)
10. K Crump: Critical issues in benchmark calculations from continuous data. Crit Rev Toxicol 32, 133-153 (2002)
11. KS Crump, C Van Landingham, C Shamlaye, C Cox, PW Davidson, GJ Myers and TW Clarkson: Benchmark concentrations for methylmercury obtained from the Seychelles Child Development Study. Environ Health Perspect 108, 257-263 (2000)
12. KS Crump, T Kjellström, AM Shipp, A Silvers and A Stewart: Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand Cohort. Risk Anal 18, 701-713 (1998)
13. E Budtz-Jørgensen, N Keiding and P Grandjean: Benchmark dose calculation from epidemiological data. Biometrics 57, 698-706 (2001)
14. K Murata, E Budtz-Jørgensen and P Grandjean: Benchmark dose calculations for methylmercury-associated delays on evoked potential latencies in two cohorts of children. Risk Anal 22, 465-474 (2002)
15. EK Silbergeld: Lead poisoning: the implications of current biomedical knowledge for public policy. Md Med J 45, 209-217 (1996)
16. T Sakai and Y Morita: δ-Aminolevulinic acid in plasma or whole blood as a sensitive indicator of lead effects, and its relation to the other heme-related parameters. Int Arch Occup Environ Health 68, 126-132 (1996)
17. Y Morita, T Sakai, S Araki, T Araki and Y Masuyama: Usefulness of δ-aminolevulinic acid in blood as an indicator of lead exposure. Jpn J Ind Health 35, 112-118 (1993)
18. Y Morita, S Araki, T Sakai, T Araki and Y Masuyama: Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: a sensitive indicator of lead effects. Ind Health 32, 85-96 (1994)
19. A Okayama, S Fujii and R Miura: Optimized fluorometric determination of urinary δ-aminolevulinic acid by using precolumn derivatization, and identification of the derivative. Clin Chem 36, 1494-1497 (1990)
20. T Sakai, S Yanagihara and K Ushio: Restoration of lead-inhibited δ-aminolevulinate dehydratase activity in whole blood by heat, zinc ion, and (or) dithiothreitol. Clin Chem 26, 625-628 (1980)
21. Murata K, Yano E. Medical Statistics for Evidence-Based Medicine with SPBS User's Guide. Tokyo: Nankodo Publisher, 2002
22. Y Morita, T Sakai, T Araki, K Suzuki, K Oda, S Araki and Y Masuyama: A reference value for delta-aminolevulinic acid in plasma in the population occupationally unexposed to lead. Ind Health 34, 57-60 (1996)
23. T Sakai, Y Morita, T Araki, M Kano and T Yoshida: Relationship between delta-aminolevulinic acid dehydratase genotypes and heme precursors in lead workers. Am J Ind Med 38, 355-360 (2000)
24. MR Moore, A Goldberg and AAC Young-Laiwah: Lead effects on the haem-biosynthetic pathway: relationship to toxicity. Ann NY Acad Sci 514, 191-203 (1987)
25. JJ Chisolm, DJ Thomas and TG Hamill: Erythrocyte porphobilinogen synthase activity as an indicator of lead exposure to children. Clin Chem 31, 601-605 (1985)